in the Philippines
Phase of Your Trial
Advancing Trials Together
Welcome to Harmony Trials, a Contract Research Organization (CRO) providing expert-driven clinical research services in the Philippines – a leading destination for clinical trials in Southeast Asia. Harmony Trials delivers comprehensive support for Phase IB to IV clinical trials, including regulatory, monitoring, and site management services.
Our leadership team and key clinical research professionals bring over 20 years of industry experience, having collectively supported more than 100 clinical trials involving over 80,000 participants across various therapeutic areas such as infectious diseases, oncology, pulmonology, rheumatology, and vaccines. Harmony Trials is committed to advancing trials throughout the Philippines.
Harmony Trials is registered with the Securities & Exchange Commission with a registration number of 2024110176259-04, and the Philippine Food & Drug Administration with a CRO License to Operate of CDRR-NCR-CRO-1308490.
Why Choose the Philippines?
- Globally Ranked Hospitals: Included in the Newsweek World’s Best Hospitals 2026 evaluation, 33 local institutions were globally recognized, including 2 hospitals breaking into the Top 250 World’s Best Hospitals.[1]
- Expanding Market: Total Health Expenditure reached $25.35 billion USD (PHP 1.56 trillion, making up 5.9% of the GDP), marking a 17.1% year-on-year increase.[2]
- Massive English-Fluent Workforce: The local clinical system is powered by over 248,500 healthcare workers nationwide. The vast majority of these professionals are fully fluent and proficient in English. [2]
- English Documentation: All regulatory submissions, clinical protocols, and medical data records are entirely drafted and processed in English. [3]
- USFDA Validated: 19 inspections completed with 100% compliant NAI (No Actions Indicated) / VAI (Voluntary Actions Indicated) ratings. [4]
Patient Demographics & Pediatric Study Potential [2]
- 1. Total Country Population: 112,729,484 people
- 2. Pediatric Cohort (Aged 0–14):
- National total fertility rate of 1.9 children per woman
- Children represent roughly 27% of the total population
- A pool of 30.4 million children for pediatric and neonatal studies.
- 3. Annual Newborns: 1,358,989 live births annually
Top Mortality Drivers [2]
Ischaemic Heart Diseases
Neoplasms / Cancers
Cerebrovascular Diseases / Stroke
Pneumonia
Diabetes Mellitus
Track Record: Clinical Trials by Phase [5]
According to data from ClinicalTrials.gov, the Philippines has participated in about 1,000 studies. The country excels in late-phase clinical development, with the majority of studies focused on Phase III:
